In a Form 4 filing with the SEC, CEO, 10% Owner of MannKind Corp. (MNKD), discloses buying 700,000 shares of MNKD on 01/12/2011 at an average price of $8.71 p/sh for a total of $2,800,000.
MannKind Corp has a market cap of $1.12 billion; its shares were trading during Wednesday afternoon trading at around $9.01 with a PEG ratio of (0.10).
Mankind is a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer. The co. was founded in 1991 and is based in Valencia, California.
Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!